See also the Agenda, Questions and Briefing Materials

[Federal Register: March 19, 2002 (Volume 67, Number 53)]
[Notices]
[Page 12571-12572]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19mr02-98]
 
-----------------------------------------------------------------------
 
DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
Food and Drug Administration
 
 
Food Advisory Committee; Notice of Meeting
 
AGENCY: Food and Drug Administration, HHS.
 
ACTION: Notice.
 
-----------------------------------------------------------------------
 
SUMMARY: This notice announces a forthcoming meeting of a public
advisory committee of the Food and Drug Administration (FDA). The
meeting will be open to the public.
    Name of Committee: Food Advisory Committee.
    General Function of the Committee: To provide advice and
recommendations to the agency on scientific issues related to FDA's
regulatory responsibilities.
    Date and Time: The meeting will be held on April 4, 2002, from 9
a.m. to 6 p.m. and April 5, 2002, from 8:30 a.m. to 2 p.m.
    Location: Marriott Hotel, Grand Ballroom, 6400 Ivy Lane, Greenbelt,
MD, 301-441-3700.
    Contact Person: Catherine M. DeRoever, Center for Food Safety and
Applied Nutrition (HFS-6), Food and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740, 301-436-2397, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 10564. Please call the Information Line for
up-to-date information on this meeting.
 
[[Page 12572]]
 
    Agenda: The purpose of this meeting is to discuss general
scientific principles related to quality factors for infant formula.
The committee will also be asked to discuss the scientific issues
related to the generalization of findings from a clinical study using
preterm infant formula consumed by preterm infants to a term infant
formula intended for use by term infants.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by April 1, 2002.
Oral presentations from the public will be scheduled on April 4, 2002,
between approximately 1 p.m. and 6 p.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before April 1, 2002,
and submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
    Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Catherine M.
DeRoever at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
 
    Dated: March 14, 2002.
Linda A. Suydam,
Senior Associate Commissioner for Communications and Constituent
Relations.
[FR Doc. 02-6620 Filed 3-14-02; 4:50 pm]
BILLING CODE 4160-01-S

Agenda, Questions and Briefing Materials